HIV-1 Tat reduces nephrin in human podocytes: A potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy

AIDS

Volumn 21, Issue 4, 2007, Pages 423-432

  Doublier, Sophie ^a   Zennaro, Cristina ^b,c   Spatola, Tiziana ^a   Lupia, Enrico ^d   Bottelli, Antonella ^e   Deregibus, Maria Chiara ^a   Carraro, Michele ^b   Conaldi, Pier Giulio ^e,f   Camussi, Giovanni ^a,g  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^g Dipartimento di Medicina Interna   (Italy)

Author keywords

Glomerular permeability; HIV 1 Tat; Nephrin; Platelet activating factor; Podocytes

Indexed keywords

ALBUMIN; NEPHRIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TRANSACTIVATOR PROTEIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VIRUS PROTEIN; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; GENETIC TRANSFECTION; GLOMERULUS; GLOMERULUS FILTRATION; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; KIDNEY DISEASE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEINURIA; RAT; ULTRAFILTRATION; WESTERN BLOTTING;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; CELLS, CULTURED; CYTOSKELETON; GENE PRODUCTS, TAT; HIV-1; HUMANS; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; PERMEABILITY; PODOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SERUM ALBUMIN; TISSUE CULTURE TECHNIQUES; TRANSFECTION;

EID: 33847043565     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328012c522     Document Type: Article

References (50)

1. Weiner NJ, Goodman JW, Kimmel PL. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 2003; 63:1618-1631.
2. Ross MJ, Klotman PE. HIV-associated nephropathy. AIDS 2004; 18:1089-1099.
3. Rao TKS. Human immunodeficiency virus infection in endstage renal disease patients. Semin Dial 2003; 16:233-244.
4. D'Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998; 18:406-421.
5. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-asociated nephropathy. J Am Soc Nephrol 1999; 10:51-61.
6. Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003; 139:218-220.
7. Herman ES, Klotman PE. HIV-associated nephropathy: epidemiology, pathogenesis, and treatment. Semin Nephrol 2003; 23:200-208.
8. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A 1992; 89:1577-1581.
9. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997; 100:84-92.
10. Bruggeman LA, Ross MD, Tanji N, Cara A, Dickman S, Gordon RE, et al. Renal epithelium is a previously unrecognised site of HIV-1 infection. J Am Soc Nephrol 2000; 11:2079-2087.
11. Yamamoto T, Noble NA, Miller DE, Gold LI, Hishida A, Nagase M, et al. Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int 1999; 55:579-592.
12. Strebel K. Virus-host interactions: role of HIV proteins Vif, Tat, and Rev. AIDS 2003; 17 (Suppl. 4):S25-S34.
13. Conaldi PG, Bottelli A, Baj A, Serra C, Fiore L, Federico G, et al. Human immunodeficiency virus-1 Tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 2002; 161:53-61.
14. Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 1999; 10:2440-2445.
15. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1:575-582.
16. Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthofer H, Zaoui P, et al. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002; 45:1572-1576.
17. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52:1023-1030.
18. Doublier S, Ruotsalainen V, Salvidio G, Lupia E, Biancone L, Conaldi PG, et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 2001; 158:1723-1731.
19. Topham PS, Kawachi H, Haydar SA, Chugh S, Addona TA, Charron KB, et al. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 1999; 104:1559-1566.
20. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, et al. Nephrin in experimental glomerular disease. Kidney Int 2000; 58:1461-1468.
21. Savin VJ, Sharma R, Lowell HB, Welling DJ. Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 1992; 3:1260-1269.
22. Candiano G, Musante L, Carraro M, Faccini L, Campanacci L, Zennaro C, et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12:143-150.
23. Conaldi PG, Biancone L, Bottelli A, De Martino A, Camussi G, Toniolo A. Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol 1997; 71:9180-9187.
24. Bussolati B, Deregibus MC, Fonsato V, Doublier S, Spatola T, Procida S, et al. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidyinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol 2005; 16:1936-1947.
25. Montrucchio G, Lupia E, De Martino A, Silvestro L, Savu SR, Cacace G, et al. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet-activating factor and P-selectin. Circulation 1996; 93:2152-2160.
26. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83:253-307.
27. Yuan H, Takeuchi E, Salant DJ. Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am J Physiol Renal Physiol 2002; 282:F585-F591.
28. Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, et al. Microfilaments in cellular and developmental processes. Science 1971; 171:135-143.
29. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, et al. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 1996; 12:1371-1375.
30. Mitola S, Sozzani S, Luini W, Primo L, Borsatti A, Weich H, et al. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 1997; 4:1365-1372.
31. Arese M, Ferrandis C, Camussi G, Bussolino F. HIV-1 Tat Protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. J Immunol 2001; 166:1380-1388.
32. Barillari G, Sgadari C, Fiorelli V, Samaniego F, Colombini S, Manzari V, et al. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 1999; 94:663-672.
33. Del Sorbo L, DeMartino A, Biancone L, Bussolati B, Conaldi PG, Toniolo A, et al. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. Eur J Immunol 1999; 29:1513-1521.
34. Biancone L, Cantaluppi V, Boccellino M, Bussolati B, Del Sorbo L, Conaldi PG, et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. Am J Pathol 1999; 155:1731-1739.
35. Del Sorbo L, Arese M, Giraudo E, Tizzani M, Biancone L, Bussolino F, et al. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. Eur J Immunol 2001; 31:376-383.
36. Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D'Agati VD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344:1979-1984.
37. Schwartz EJ, Klotman PE. Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 1998; 18:436-445.
38. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, et al. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 1998; 102:2041-2049.
39. Conaldi PG, Bottelli A, Wade-Evans A, Biancone L, Baj A, Cantaluppi V, et al. HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS 2000; 14:2045-2047.
40. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005; 68:1048-1060.
41. Green DF, Resnick L, Bourgoignie JJ. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 1992; 41:956-960.
42. Jones KA, Peterlin MB. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1994; 63:717-743.
43. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997; 11:1421-1431.
44. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, et al. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 2000; 6:1380-1387.
45. Jeang KT, Xiao H, Rich EA. Multifaceted activities of the HIV-1 transactivator of transcription. Tat J Biol Chem 1999; 274:22837-22840.
46. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La PM. Tat protein stimulates production of transforming growth factorbeta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992; 80:3036-3043.
47. Westendorp MO, Li WM, Frank RW, Krammer PH. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994; 68:4177-4185.
48. Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassare F, et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 1994; 179:961-971.
49. Viscidi RP, Mayur K, Lederman HM, Frankel AD. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV. Science 1989; 246:1606-1608.
50. Ensoli B, Bacillari G, Salahuddin SZ, Gallo R, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990; 345:84-86.